ARCHIVES

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 26 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

First “Annual” CCOP RFA Issued; Research Bases Must Compete

June 8, 1990

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal

February 5, 1993